MRX revenueFY2025$2.02B
- FY YoY
- +26.9%
MRX revenue was $2.02B for fiscal 2025 (ended Dec 31, 2025), up 26.9% from fiscal 2024. It rose in each of the last 3 fiscal years.
For fiscal 2025 (ended Dec 31, 2025), Marex Group Limited reported $2.02B of revenue and $293.90M of net income.
MRX revenue was $2.02B for fiscal 2025 (ended Dec 31, 2025), up 26.9% from fiscal 2024. It rose in each of the last 3 fiscal years.
MRX net income was $293.90M for fiscal 2025 (ended Dec 31, 2025), up 43.6% from fiscal 2024. It rose in each of the last 3 fiscal years.
MRX diluted EPS was $3.86 for fiscal 2025 (ended Dec 31, 2025), up 41.9% from fiscal 2024.
MRX free cash flow was $654.40M for fiscal 2025 (ended Dec 31, 2025), down 43.2% from fiscal 2024. It rose in 2 of the last 3 fiscal years.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | $2.02B | $1.59B | $1.24B | $711.10M |
| Interest expense | $760.20M | $538.10M | $470.20M | $165.00M |
| Pre-tax income | $411.60M | $295.80M | $196.50M | $121.60M |
| Income tax | $103.70M | $77.80M | $55.20M | $23.40M |
| Net income | $293.90M | $204.70M | $128.00M | $91.60M |
| EPS, basic | $4.12 | $2.96 | $1.94 | $1.39 |
| EPS, diluted | $3.86 | $2.72 | $1.82 | $1.36 |
| Diluted shares | 76.1M | 75.3M | 70.3M | 67.6M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Cash and equivalents | $2.88B | $2.56B | $1.48B | $910.10M |
| Short-term investments | - | $87.70M | $76.70M | $0 |
| Receivables | $10.99B | $7.55B | $4.79B | $4.69B |
| Current assets | $33.70B | $23.83B | $16.94B | $15.35B |
| Goodwill | $237.40M | $176.50M | $163.60M | $155.50M |
| Total assets | $34.68B | $24.31B | $17.61B | $15.74B |
| Current liabilities | $30.96B | $21.78B | $15.88B | $14.56B |
| Short-term debt | $200.00M | $152.00M | $0 | $12.90M |
| Long-term debt | $0 | $0 | $0 | $135.80M |
| Total debt | $200.00M | $152.00M | $0 | $148.70M |
| Total liabilities | $33.41B | $23.34B | $16.84B | $15.07B |
| Shareholders' equity | $1.17B | $879.30M | $775.90M | $677.70M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Operating cash flow | $667.50M | $1.16B | $735.00M | $225.60M |
| Capital expenditures | $13.10M | $11.70M | $9.00M | $3.60M |
| Free cash flow | $654.40M | $1.15B | $726.00M | $222.00M |
| Investing cash flow | -$264.30M | -$35.30M | -$97.60M | -$46.30M |
| Financing cash flow | -$123.90M | -$37.20M | -$72.80M | $26.50M |
| Dividends paid | $55.50M | $77.10M | $58.30M | $6.60M |
| Share repurchases | $44.10M | $19.80M | $3.10M | $7.90M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue growth, YoY | 26.9% | 28.1% | 75.0% | - |
| Net income growth, YoY | 43.6% | 59.9% | 39.7% | - |
| EPS growth, YoY | 41.9% | 49.5% | 33.8% | - |
| Net margin | 14.5% | 12.8% | 10.3% | 12.9% |
| Free cash flow margin | 32.3% | 72.2% | 58.3% | 31.2% |
| Return on equity | 25.2% | 23.3% | 16.5% | 13.5% |
| Return on assets | 0.8% | 0.8% | 0.7% | 0.6% |
| Current ratio | 1.09 | 1.09 | 1.07 | 1.05 |
| Debt to equity | 0.17 | 0.17 | 0.00 | 0.22 |
Source: XBRL data Marex Group Limited files with the SEC, latest filing dated Mar 25, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| MRX | $2.02B | +26.9% | $293.90M | 14.5% | $5.03B |
| MS | $80.16B | +16.2% | $20.45B | 25.5% | $292.45B |
| GS | $69.70B | +18.7% | $22.17B | 31.8% | $261.38B |
| BLK | $28.54B | +24.7% | $6.91B | 24.2% | $187.58B |
| SCHW | $27.06B | +18.1% | $10.64B | 39.3% | $160.36B |
| CME | $6.97B | +9.0% | $4.43B | 63.5% | $109.00B |
| ICE | $14.05B | +12.1% | $4.16B | 29.6% | $97.26B |
| HOOD | $5.08B | +20.9% | $1.98B | 39.0% | $75.03B |
| NDAQ | $9.15B | +11.5% | $2.08B | 22.8% | $60.21B |